Sepsis remains a significant cause of neonatal mortality and morbidity, especially in low-and
middle-income countries. Neonatal sepsis presents with nonspecific signs and symptoms …

Sepsis is an important cause of mortality and morbidity in neonatal populations. There has
been constant search of an ideal sepsis biomarker that have high sensitivity, specificity …

Sepsis remains a leading cause of death worldwide, despite advances in critical care, and
understanding of the pathophysiology and treatment strategies. No specific therapy or drugs …

As neonatal sepsis is a severe condition, there is a call for reliable biomarkers to
differentiate between infected and noninfected newborns. Although blood culture has been …

Every year numerous individuals develop the morbid condition of sepsis. Therefore, novel
biomarkers that might better inform clinicians treating such patients are sorely needed …

Neonatal sepsis is a bacterial bloodstream infection leading to severe clinical manifestations
frequently associated with death or irreversible long-term deficits. Antibiotics are the drug of …

Objective The red blood cell distribution width (RDW) and neutrophil/lymphocyte ratio (NLR)
are increased in various inflammation related diseases, but their clinical significance in …

Sepsis and necrotizing enterocolitis are major contributors to morbidity and mortality in
neonates, especially in those born preterm. While therapeutic interventions are available for …

Introduction Acute-on-chronic failure (ACLF) is a recognized syndrome in patients with
chronic liver disease and is characterized by acute decompensation, organ failure (s), and a …

Sepsis, an under-recognized health problem, is a major cause of death. More than 750,000
individuals develop sepsis annually, of whom 215,000 die of the disease. Clinical and …